{
    "name": "mometasone inhaled",
    "comment": "Rx",
    "other_names": [
        "Asmanex Twisthaler",
        "Asmanex HFA"
    ],
    "classes": [
        "Corticosteroids",
        "Inhalants"
    ],
    "source": "https://reference.medscape.com/drug/asmanex-twisthaler-asmanex-hfa-mometasone-inhaled-343406",
    "pregnancy": {
        "common": [
            "There are no randomized clinical studies in pregnant women"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "In animal reproduction studies with pregnant mice, rats, or rabbits, mometasone furoate caused increased fetal malformations and decreased fetal survival and growth following administration of doses that produced exposures ~1/3 to 8 times the maximum recommended human dose (MRHD) on a mcg/m2 or AUC basis",
                    "However, experience with oral corticosteroids suggests that rodents are more prone to teratogenic effects from corticosteroid exposure than humans"
                ]
            },
            {
                "type": "Clinical considerations",
                "description": [
                    "In women with poorly or moderately controlled asthma, there is an increased risk of several perinatal adverse outcomes such as preeclampsia in the mother and prematurity, low birth weight, and small for gestational age in the neonate",
                    "Closely monitor pregnant women with asthma and adjust medication as necessary to maintain optimal asthma control"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "There are no available data on the presence in human milk, the effects on the breastfed child, or the effects on milk production",
            "Other inhaled corticosteroids, similar to mometasone furoate, are present in human milk",
            "Consider developmental and health benefits of breastfeeding along with the motherâ€™s clinical need and any potential adverse effects on the breastfed infant from mometasone inhaled or from the underlying maternal condition"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity",
                "Immunosuppressed patients",
                "Tuberculosis",
                "Status asthmaticus or other acute asthma episode necessitating intensive measures",
                "Known hypersensitivity to milk proteins or any other ingredients"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Not a bronchodilator; not indicated for rapid relief of bronchospasm or other acute episodes of asthma; a short-acting beta2-agonist, such as albuterol, should be available at all times to treat acute asthma symptoms; instruct patients to contact their physician immediately if episodes of asthma that are not responsive to bronchodilators occur during course of treatment; during such episodes, patients may require therapy with oral corticosteroids",
                "Unmasking of allergic conditions previously suppressed by systemic corticosteroids may occur upon transferring from systemic corticosteroid therapy",
                "Respiratory tract tuberculosis, untreated fungal or bacterial infections, viral or parasitic infections, ocular herpes simplex",
                "Nasal septum perforation, epistaxis, wheezing",
                "Cataracts, glaucoma, increased intraocular pressure reported; consider referral to an ophthalmologist in patients who develop ocular symptoms or long term therapy",
                "Risk of more serious or fatal course of chickenpox and measles in susceptible individuals; avoid use in unvaccinated or immunologically unexposed children or adults",
                "Deaths from adrenal insufficiency have occurred after abrupt withdrawal of oral steroids; taper withdrawal gradually",
                "May retard growth in children",
                "Immunocompromised patients",
                "Excessive use may suppress hypothalamic-pituitary-adrenal function",
                "During periods of stress or severe status asthmaticus, patient may require supplementary systemic corticosteroids immediately; carry warning card to that effect",
                "Long-term administration reduces bone mineral density"
            ],
            "specific": [
                {
                    "type": "Fungal infections",
                    "description": [
                        "Localized infections of the mouth and pharynx with ",
                        "Candida albicans ",
                        "reported; if oropharyngeal candidiasis develops, treat with appropriate local or systemic (i.e., oral) antifungal therapy while remaining on treatment; at times therapy may need to be interrupted",
                        "To reduce risk of oropharyngeal candidiasis, after dosing, advise patients to rinse their mouth with water and spit out the contents without swallowing"
                    ]
                },
                {
                    "type": "Drug interaction overview",
                    "description": [
                        "Strong CYP3A4 inhibitors (eg, ritonavir): Use with caution; may cause increased systemic corticosteroid effects"
                    ]
                }
            ]
        }
    },
    "interactions": [
        {
            "classification_type": "Serious",
            "interaction_with": "aldesleukin",
            "description": {
                "common": "mometasone inhaled decreases effects of aldesleukin by Other (see comment). Avoid or Use Alternate Drug. \nComment: Corticosteroids may interfere with antitumor effects of aldesleukin."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "desmopressin",
            "description": {
                "common": "mometasone inhaled increases toxicity of desmopressin by Other (see comment). Avoid or Use Alternate Drug. \nComment: Corticosteroids may enhance the hyponatremic effect of intranasal desmopressin."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "loxapine inhaled",
            "description": {
                "common": "mometasone inhaled increases toxicity of loxapine inhaled by Other (see comment). Avoid or Use Alternate Drug. \nComment: Agents used to treat airway disease may enhance the toxic effect of inhaled loxapine."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "amphotericin B deoxycholate",
            "description": {
                "common": "mometasone inhaled increases toxicity of amphotericin B deoxycholate by Other (see comment). Use Caution/Monitor. \nComment: Corticosteroids may enhance the hypokalemic effect of amphtericin B. ."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "atazanavir",
            "description": {
                "common": "atazanavir increases levels of mometasone inhaled by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Potential for increased toxicity. Increased risk of Cushing's syndrome or adrenal suppression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "bumetanide",
            "description": {
                "common": "mometasone inhaled increases toxicity of bumetanide by Other (see comment). Use Caution/Monitor. \nComment: Corticosteroids may increase hypokalemic effect of loop diuretics."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "ceritinib",
            "description": {
                "common": "mometasone inhaled increases toxicity of ceritinib by Other (see comment). Use Caution/Monitor. \nComment: Corticosteroids may increase hypoglycemic effects of ceritinib."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "chlorothiazide",
            "description": {
                "common": "mometasone inhaled increases toxicity of chlorothiazide by Other (see comment). Use Caution/Monitor. \nComment: Corticosteroids may increase hypokalemic effect of loop diuretics."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "chlorthalidone",
            "description": {
                "common": "mometasone inhaled increases toxicity of chlorthalidone by Other (see comment). Use Caution/Monitor. \nComment: Corticosteroids may increase hypokalemic effect of loop diuretics."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "ciprofloxacin",
            "description": {
                "common": "mometasone inhaled and ciprofloxacin both increase  Other (see comment). Use Caution/Monitor. Coadministration of quinolone antibiotics and corticosteroids may increase risk of tendon rupture."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "clarithromycin",
            "description": {
                "common": "clarithromycin will increase the level or effect of mometasone inhaled by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Increases riak for systemic corticosteroid side effects"
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "cobicistat",
            "description": {
                "common": "cobicistat will increase the level or effect of mometasone inhaled by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Increases risk for systemic corticosteroid side effects"
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "corticorelin",
            "description": {
                "common": "mometasone inhaled decreases effects of corticorelin by Other (see comment). Use Caution/Monitor. \nComment: Corticosteroids may blunt plasma ACTH response to corticorelin."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "darunavir",
            "description": {
                "common": "darunavir increases levels of mometasone inhaled by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Potential for increased toxicity. Increased risk of Cushing's syndrome or adrenal suppression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "deferasirox",
            "description": {
                "common": "mometasone inhaled increases toxicity of deferasirox by Other (see comment). Use Caution/Monitor. \nComment: Corticosteroids increase risk of gastrointestinal ulceration/irritation."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "elvitegravir/cobicistat/emtricitabine/tenofovir DF",
            "description": {
                "common": "elvitegravir/cobicistat/emtricitabine/tenofovir DF will increase the level or effect of mometasone inhaled by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Increases riak for systemic corticosteroid side effects"
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "ethacrynic acid",
            "description": {
                "common": "mometasone inhaled increases toxicity of ethacrynic acid by Other (see comment). Use Caution/Monitor. \nComment: Corticosteroids may increase hypokalemic effect of loop diuretics."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "fosamprenavir",
            "description": {
                "common": "fosamprenavir increases levels of mometasone inhaled by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Potential for increased toxicity. Increased risk of Cushing's syndrome or adrenal suppression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "furosemide",
            "description": {
                "common": "mometasone inhaled increases toxicity of furosemide by Other (see comment). Use Caution/Monitor. \nComment: Corticosteroids may increase hypokalemic effect of loop diuretics."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "gemifloxacin",
            "description": {
                "common": "mometasone inhaled and gemifloxacin both increase  Other (see comment). Use Caution/Monitor. Coadministration of quinolone antibiotics and corticosteroids may increase risk of tendon rupture."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "hyaluronidase",
            "description": {
                "common": "mometasone inhaled decreases effects of hyaluronidase by Other (see comment). Modify Therapy/Monitor Closely. \nComment: Corticosteroids may decrease therapeutic effects of hyaluronidase."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "hydrochlorothiazide",
            "description": {
                "common": "mometasone inhaled increases toxicity of hydrochlorothiazide by Other (see comment). Use Caution/Monitor. \nComment: Corticosteroids may increase hypokalemic effect of loop diuretics."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "indinavir",
            "description": {
                "common": "indinavir increases levels of mometasone inhaled by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Potential for increased toxicity. Increased risk of Cushing's syndrome or adrenal suppression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "itraconazole",
            "description": {
                "common": "itraconazole will increase the level or effect of mometasone inhaled by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Increases risk for systemic corticosteroid side effects"
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "ketoconazole",
            "description": {
                "common": "ketoconazole will increase the level or effect of mometasone inhaled by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Increases riak for systemic corticosteroid side effects"
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "letermovir",
            "description": {
                "common": "letermovir increases levels of mometasone inhaled by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "levofloxacin",
            "description": {
                "common": "mometasone inhaled and levofloxacin both increase  Other (see comment). Use Caution/Monitor. Coadministration of quinolone antibiotics and corticosteroids may increase risk of tendon rupture."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "levoketoconazole",
            "description": {
                "common": "levoketoconazole will increase the level or effect of mometasone inhaled by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Increases riak for systemic corticosteroid side effects"
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "lopinavir",
            "description": {
                "common": "lopinavir increases levels of mometasone inhaled by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Potential for increased toxicity. Increased risk of Cushing's syndrome or adrenal suppression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "moxifloxacin",
            "description": {
                "common": "mometasone inhaled and moxifloxacin both increase  Other (see comment). Use Caution/Monitor. Coadministration of quinolone antibiotics and corticosteroids may increase risk of tendon rupture."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "nefazodone",
            "description": {
                "common": "nefazodone will increase the level or effect of mometasone inhaled by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Increases riak for systemic corticosteroid side effects"
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "nelfinavir",
            "description": {
                "common": "nelfinavir increases levels of mometasone inhaled by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Potential for increased toxicity. Increased risk of Cushing's syndrome or adrenal suppression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "nirmatrelvir",
            "description": {
                "common": "nirmatrelvir will increase the level or effect of mometasone inhaled by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Coadministration may increase certain systemic corticosteroid concentrations. Increased risk for Cushing syndrome and adrenal suppression. Consider alternant corticosteroids, including beclomethasone and prednisolone)."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "nirmatrelvir/ritonavir",
            "description": {
                "common": "nirmatrelvir/ritonavir will increase the level or effect of mometasone inhaled by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Coadministration may increase certain systemic corticosteroid concentrations. Increased risk for Cushing syndrome and adrenal suppression. Consider alternant corticosteroids, including beclomethasone and prednisolone)."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "ofloxacin",
            "description": {
                "common": "mometasone inhaled and ofloxacin both increase  Other (see comment). Use Caution/Monitor. Coadministration of quinolone antibiotics and corticosteroids may increase risk of tendon rupture."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "ribociclib",
            "description": {
                "common": "ribociclib will increase the level or effect of mometasone inhaled by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "ritonavir",
            "description": {
                "common": "ritonavir increases levels of mometasone inhaled by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Potential for increased toxicity. Increased risk of Cushing's syndrome or adrenal suppression."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "saquinavir",
            "description": {
                "common": "saquinavir will increase the level or effect of mometasone inhaled by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Increases riak for systemic corticosteroid side effects"
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "torsemide",
            "description": {
                "common": "mometasone inhaled increases toxicity of torsemide by Other (see comment). Use Caution/Monitor. \nComment: Corticosteroids may increase hypokalemic effect of loop diuretics."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Headache",
            "percent": "26"
        },
        {
            "name": "Viral infection",
            "percent": "14"
        },
        {
            "name": "Pharyngitis",
            "percent": "12"
        },
        {
            "name": "Epistaxis",
            "percent": "11"
        },
        {
            "name": "Cough",
            "percent": "7"
        },
        {
            "name": "Upper respiratory tract infection",
            "percent": "6"
        },
        {
            "name": "Dysmenorrhea",
            "percent": "5"
        },
        {
            "name": "Loss of taste",
            "percent": null
        },
        {
            "name": "Muscle soreness",
            "percent": null
        },
        {
            "name": "Vision blurred",
            "percent": null
        }
    ]
}